Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
302 results found
2026
Recommendations and guidance for pneumococcal vaccination for adults
Western Pacific Pneumococcal disease
Download:
2026 ∙ Ministério da Saúde
Introduction of the 20-valent pneumococcal vaccine (conjugate) into the national immunization program
Americas Brazil recommendation Pneumococcal disease
Download:
2026
25th Meeting of the European Technical Advisory Group of Experts on immunization (ETAGE): 17–18 November 2025
Europe Pneumococcal disease Varicella Herpes zoster
Download:
2026 ∙ Faijue, D. D. Bouaddi, O. Mackey, K. Deal, A. Cinar, E. N. Morais, B. Bojang, S. Al-Sharabi, I. Seale, H. Ssali, A. Le Doare, K. Hargreaves, S.
Strategies, interventions, and uptake of catch-up vaccination among adolescent and adult migrants, refugees, and internally displaced persons (IDPs) in low- and middle-income countries (LMICs): A systematic review
Adolescents Adults Low and Middle Income Countries Measles Rubella COVID-19 Human papillomavirus (HPV) Poliomyelitis Hepatitis B Tetanus Pertussis Diphtheria Pneumococcal disease Typhoid Meningococcal disease Coverage Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2026
Recommendations for pneumococcus 2026
Americas Pneumococcal disease
Download:
2026
Recommendations on pneumococcal vaccination to at-risk groups
Recommendation Europe Sweden Risk group Pneumococcal disease
Download:
2026 ∙ STIKO
Update of the STIKO recommendation on vaccination against pneumococcal disease for children and adolescents with risk factors aged ≥ 2 to 17 years
Recommendation Europe Germany children adolescents Risk group Pneumococcal disease
Download:
2025 ∙ Maggi, S. Fulop, T. De Vita, E. Limongi, F. Pizzol, D. Di Gennaro, F. Veronese, N.
Association between vaccinations and risk of dementia: A systematic review and meta-analysis
Adults Older adults COVID-19 Herpes zoster Tetanus Diphtheria Pertussis Influenza Pneumococcal disease Poliomyelitis Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Vink, K. Kusters, J. Wallinga, J.
Chrono-optimizing vaccine administration: a systematic review and meta-analysis
Adults Older adults COVID-19 Influenza Hepatitis B Hepatitis A Pneumococcal disease Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Fletcher, M. A. Okasha, O. Baay, M. Syrochkina, M. Hayford, K.
Complicated pneumococcal pneumonia in the era of higher-valent pneumococcal conjugate vaccines: a systematic literature review and meta-analysis, 2001-2022
All age groups Pneumococcal disease Administration Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...